| dbGAP Study | dbGAP Variable | dbGAP Variable Description |
| A Genome-Wide Association Study of Peripheral Arterial Disease |
phv00076111 |
Gender of participant |
| A Novel Recurrent Mutation in MITF Predisposes to Familial and Sporadic Melanoma |
phv00164876 |
Gender of participant |
| Abundant Quantitative Trait Loci Exist for DNA Methylation and Gene Expression in Human Brain |
phv00121765 |
Gender of subject |
| Acquired Copy Number Alterations in Adult Acute Myeloid Leukemia Genomes |
phv00076146 |
Gender of participant |
| ADGC Genome Wide Association Study |
phv00171927 |
Gender of participant |
| African American Breast Cancer GWAS |
phv00226032 |
Gender of participant |
| Alcohol Dependence GWAS in European- and African Americans |
phv00164977 |
Gender of participant |
| AMD-MMAP Cohort Study: A Joint Genome Wide Association Study |
phv00073523 |
Gender of participant |
| Antigen Discovery in Melanoma |
phv00253333 |
Sex of subject |
| ARRA Autism Sequencing Collaboration |
phv00167339 |
Gender of participant |
| Asian Indian Diabetic Heart Study (AIDHS) |
phv00190530 |
Gender of participant |
| Autopsy-Confirmed Parkinson Disease GWAS Consortium (APDGC) |
phv00167765 |
Gender of participant |
| Autosomal recessive PGM3 mutations cause a new Congenital Disorder of Glycosylation |
phv00219152 |
Gender of participant |
| Autosomal recessive TPP2 mutations cause a new human immunodeficiency |
phv00221156 |
Gender of participant |
| B and T Cell Determinants of Influenza Vaccine Responses in the Elderly |
phv00196119 |
Gender of participant |
| Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans |
phv00173359 |
Sex of participant |
| Biology and Molecular Analysis of Human Hematopoiesis Genetics |
phv00168002 |
Gender of participant |
| Bladder Cancer Clinical Cohorts |
phv00202613 |
Gender of participant |
| BrainCloud: Data from Human Postmortem Brain Across the Lifespan |
phv00163196 |
Gender of subject |
| Breakpoint Detection Using Long Insert Whole Genome Sequencing |
phv00193968 |
Gender of participant |
| Breast Cancer Study |
phv00220928 |
Gender of participant [Female] |
| Building on GWAS for NHLBI-Diseases : the U.S. CHARGE Consortium (CHARGE-S): ARIC |
phv00217501 |
Gender of participant |
| Building on GWAS for NHLBI-Diseases : the U.S. CHARGE Consortium (CHARGE-S): ARIC |
phv00217516 |
Gender of participant |
| Building on GWAS for NHLBI-Diseases : the U.S. CHARGE Consortium (CHARGE-S): ARIC |
phv00217489 |
Gender of participant |
| Bulgarian Schizophrenia Trio Sequencing Study |
phv00197315 |
Gender of participant |
| BWH MS Genetic Collection |
phv00173776 |
Gender of the participant |
| Cancer Genetic Markers of Susceptibility for Bladder Cancer (CGEMS Bladder) |
phv00159001 |
Gender of participant [ FEMALE, MALE] |
| CCDG: Dental Caries and CL/P in Guatemala |
phv00164848 |
Gender of participant. |
| CCHMC - eMERGE Data |
phv00171343 |
Gender of participant |
| CD4+ cell transcriptional profiling by RNA sequencing |
phv00193953 |
Gender of participant |
| Cebu Longitudinal Health and Nutrition Survey (CLHNS) |
phv00173303 |
Gender of participant |
| CGEMS Breast Cancer GWAS |
phv00066640 |
Gender of participant [FEMALE, MALE] |
| CGEMS Prostate Cancer GWAS - Stage 1 - PLCO |
phv00082617 |
Gender of participant |
| Characterization of a Metastatic Cervical Cancer Using NGS |
phv00195732 |
Gender of participant |
| Characterization of Human Transcriptome by Computational and HTS Approaches |
phv00224900 |
Gender of participant |
| Characterization of Pancreatic Adenocarcinoma Patients Using NGS |
phv00179509 |
Gender of participant |
| Characterization of X Chromosome Inactivation by high-throughput sequencing |
phv00219126 |
Gender of participant |
| Chinese Alternating Hemiplegia of Childhood (AHC) Disease Study |
phv00195755 |
Gender of participant |
| CHOP Control CNV Study |
phv00076212 |
Gender of participant |
| Chromothripsis in Patient WHIM-09 |
phv00222541 |
Gender of participant |
| CIDR Whole Exome Sequencing in Joubert Syndrome |
phv00161522 |
Gender of participant |
| CIDR: NGRC Parkinson's Disease Study |
phv00075993 |
Self reported male or female. |
| Ciliopathies Exome Sequencing Initiative |
phv00165082 |
Gender of subject |
| CIP: Differential Response to Hydroxyurea and Incidence of Stroke in Sickle Cell Disease |
phv00196901 |
Gender of participant |
| CIP: Obesity-Diabetes Familial Risk |
phv00191155 |
Gender of participant |
| Clonal Evolution of Pre-Leukemic HSC Precedes Human AML |
phv00173910 |
Gender of participant |
| Cohort-Based Genome-Wide Association Study of Glioma (GliomaScan) |
phv00195374 |
Gender of participant [FEMALE, MALE] |
| Colon Cancer Clinical Cohorts |
phv00224966 |
Gender of participant |
| Consanguinity and Rare Mutations Outside of MCCC Genes Underlie Non-Specific Phenotypes of MCC Deficiency |
phv00202353 |
Gender of participant |
| Copy Number Variation in Congenital Kidney Malformations |
phv00174498 |
Gender of participant |
| CPTAC Proteogenomic Confirmatory Study |
phv00225292 |
Participant gender using the defined categories. [Male; Female; Unknown; Unspecified] |
| CPTAC Proteogenomic Confirmatory Study |
phv00225344 |
Participant gender using the defined categories. [Male; Female; Unknown; Unspecified] |
| CSER-MedSeq |
phv00252786 |
Gender of subject |
| Cutaneous Microbiome in Psoriasis (HMP Demonstration Study) |
phv00090655 |
Gender of participant |
| DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00024957 |
Patient's gender |
| DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00025695 |
Patient's gender |
| DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00026039 |
Patient's gender |
| DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00027102 |
Subject's gender |
| DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00027796 |
Patient's gender (coded m or f) |
| DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00028718 |
Patient's gender (form 001) |
| DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00028966 |
Patient's gender |
| DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00029309 |
Patient's gender (from form 001) |
| DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00030102 |
Patient's gender (0=male,1=female) |
| DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00030340 |
Patient's gender |
| DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00030687 |
Patient's gender |
| DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00030750 |
Patient's gender (form 001) |
| DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00030936 |
Patient's gender (from form 001) |
| DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00034144 |
Patient's gender |
| DCEG Lung Cancer Study |
phv00159402 |
Gender of participant [FEMALE, MALE] |
| DFCI Brown Lab CLL Sequencing Study |
phv00253297 |
Gender of participant |
| DFCI Colorectal Cancer Cohorts |
phv00201985 |
Gender of participant |
| Diabetes Prevention Program Genetics (DPPG) |
phv00201854 |
Gender of participant |
| Discovery of Non-ETS Gene Fusions using RNA Sequencing |
phv00142652 |
Gender of participant |
| DNA Methylation Analysis of Prostate Cancer |
phv00181136 |
Gender of subject |
| Dobyns DBD |
phv00167279 |
Gender of participant |
| Drug Resistant Hypertension in African Americans' Exome |
phv00164734 |
Gender of participant |
| Effect of Crohn's Disease Risk Alleles on Enteric Microbiota |
phv00090595 |
Gender of participant |
| eMERGE Genome-Wide Association Studies of Obesity |
phv00163596 |
Gender of subject. |
| eMERGE Genome-Wide Association Studies of Obesity (Metabochip) |
phv00163767 |
Gender of subject. |
| eMERGE Network Combined Dataset |
phv00182445 |
Gender of participant |
| eMERGE Network Study of Resistant Hypertension |
phv00163159 |
Gender of participant. |
| Epi4K: Gene Discovery in 4,000 Epilepsy Genomes: Genetic Analyses in Epileptic Encephalopathies |
phv00195521 |
Self-declared gender of participant |
| Epi4K: Gene Discovery in 4,000 Epilepsy Genomes: Genetic Analyses in Epileptic Encephalopathies |
phv00201601 |
Self-declared gender of participant |
| Epigenetic and Genetic Profiling in Lymphoma |
phv00226818 |
Gender of participant |
| Epigenetic Marks as Peripheral Biomarkers of Autism |
phv00191073 |
Gender of participant |
| Epigenetic Profiling of Human Colorectal Cancer |
phv00161708 |
Gender of participant |
| Exome Chip Study of NIMH Controls |
phv00192229 |
Gender of participant |
| Exome Sequencing in Schizophrenia Families |
phv00201670 |
Gender of participant |
| Exome sequencing of a family with thrombocytopenia and leukemia |
phv00224938 |
Gender of participant |
| Exome Sequencing of arPEO |
phv00162961 |
Gender of Participant |
| Exome Sequencing of Esophageal Adenocarcinoma |
phv00190857 |
Participant gender as Male or Female |
| Exome Sequencing of Pleuropulmonary Blastoma |
phv00173412 |
Participant's gender as 'Male' or 'Female' |
| Familial Exome Sequencing in Rare Pediatric Phenotypes |
phv00179539 |
Gender of participant |
| Foregut Microbiome in Development of Esophageal Adenocarcinoma |
phv00090620 |
Gender of subject |
| Framingham Cohort |
phv00177929 |
Participant gender |
| FusionSeq: Finding Fusions with Paired-End RNA-Seq |
phv00156548 |
Gender of participant |
| GDNF and Anxiety |
phv00217716 |
Gender of participant |
| GEI Studies - Psoriasis |
phv00202295 |
Gender of participant |
| Geisinger eMERGE - Abdominal Aortic Aneurysm Project (AAAP) |
phv00163633 |
Gender of subject. |
| Geisinger eMERGE - MyCode Project |
phv00163391 |
Gender of subject. |
| GenADA/LONG/Imaging (Genetic Alzheimer's Disease Associations) |
phv00081063 |
Reported gender of participant |
| Gene Mutation and Rescue in Congenital Diaphragmatic Hernia |
phv00167961 |
Gender of participant |
| Genentech Lung Cancer Sequencing |
phv00112391 |
Gender of participant |
| Genentech Whole Genome Sequencing of Four Hepatocellular Carcinoma Patients |
phv00163921 |
Gender of participant |
| Genes and Blood Clotting Study (GABC) |
phv00124352 |
Participant gender |
| Genetic Analysis of Hirschsprung Disease |
phv00168116 |
Gender of participant |
| Genetic Associations in Idiopathic Talipes Equinovarus (GAIT) |
phv00141836 |
Gender of participant |
| Genetic Basis of Pulmonary Non-tuberculous Mycobacterial Infections |
phv00200422 |
Gender of participant |
| Genetic Basis of XMEN Disease |
phv00160299 |
Gender of participant |
| Genetic Defects in Familial Renal Disorders |
phv00167981 |
Gender of participant |
| Genetic Measurement of Memory B-cell Recall Using Antibody Repertoire Sequencing |
phv00195584 |
Gender of participant |
| Genetic Modifiers of Huntington's Disease |
phv00173894 |
Gender of participant |
| Genetic Variation and Signatures of Natural Selection in Diverse Africans |
phv00171014 |
Gender of participant |
| Genetic Variation and Signatures of Natural Selection in Diverse Africans |
phv00171913 |
Gender of participant |
| Genetics of High HDL Cholesterol |
phv00171948 |
Gender of participant |
| Genetics of Human Developmental Brain Disorders |
phv00168106 |
Gender of participant |
| Genetics of Inherited Muscle Disease |
phv00195631 |
Gender of participant |
| Genetics of Inherited Muscle Disease |
phv00220881 |
Gender of participant |
| Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Lipidomics Study |
phv00202103 |
Gender of participant |
| Genetics of Neuropsychiatric and Neurodevelopmental Disorders |
phv00196236 |
Gender of participant |
| Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort |
phv00165039 |
Gender of participant |
| Genome Sequencing of Hepatocellular Carcinoma |
phv00218134 |
Gender of participant |
| Genome Sequencing of Pancreatic Ductal Adenocarcinoma |
phv00171496 |
Gender of participant |
| Genome Variations Among the Aboriginals in Malaysia |
phv00195915 |
Gender of participant |
| Genome Wide Association Study in Familial Crohn's Disease |
phv00190285 |
Gender of participant |
| Genome wide association study of 24 hour urine composition in the Nurses' Health Study, Nurses' Health Study II, and the Health Professionals Follow-Up Study |
phv00165551 |
Gender of participant |
| Genome, Epigenome and RNA Sequences of MZ Twins Discordant for MS |
phv00090329 |
Gender of participant |
| Genome-Wide Analysis of Chronic Lymphocytic Leukemia |
phv00160276 |
Gender of participant |
| Genome-Wide Association Studies in Upper Gastrointestinal Cancers (Asian) |
phv00159417 |
Gender of participant [FEMALE, MALE] |
| Genome-Wide Association Study of Amyotrophic Lateral Sclerosis in Finland |
phv00158892 |
Gender of participant |
| Genome-Wide Association Study of Beh+ºet's Disease (Turkish) |
phv00124464 |
Subject gender |
| Genome-Wide Association Study of Celiac Disease |
phv00091144 |
Gender of Participant |
| Genome-wide Association Study of Myasthenia Gravis |
phv00200998 |
Gender of participant |
| Genome-Wide Association Study of Neuroblastoma |
phv00158908 |
Gender of the subject [Female, Male, Unknown] |
| Genomic Analysis of Pediatric Low Grade Gliomas |
phv00190510 |
Gender of participant |
| Genomic Characterization of Meningiomas |
phv00174205 |
Gender of participant |
| Genomic Origins and Admixture in Latinos (GOAL) |
phv00202272 |
Gender of participant |
| Genomic Predictors of Combat Stress Vulnerability and Resilience |
phv00222718 |
Gender of participant |
| Genomic Sequencing of Cervical Cancers |
phv00182022 |
Gender of participant |
| Genomic Sequencing of Pediatric Rhabdoid Cancers |
phv00171414 |
Participant gender as male or female [Male, Female] |
| Genomic Sequencing of Pediatric Rhabdomyosarcoma |
phv00201888 |
Patient gender |
| Genomic Sequencing of Solitary Fibrous Tumors |
phv00179053 |
Gender of participant |
| Genotyping 400 Samples from the NIGMS Human Variation Panels |
phv00076466 |
Gender of participant |
| Genotyping NIGMS CEPH Samples from the United States, Venezuela, and France |
phv00158856 |
Gender of participant |
| Genotyping NIGMS Chromosomal Aberration and Inherited Disorder Samples |
phv00110716 |
Gender of participant |
| Ghana Prostate Study |
phv00226956 |
Gender of participant |
| GWAS for Genetic Determinants of Bone Fragility |
phv00065502 |
Gender of participant |
| GWAS in Fibrosing Interstitial Lung Disease |
phv00201842 |
Gender of participant |
| GWAS of Breast Cancer in the African Diaspora |
phv00172015 |
Gender of participant |
| GWAS of Familial Lung Cancer |
phv00192256 |
Gender of participant |
| GWAS of Lung Cancer Susceptibility in Never-Smoking Women in Asia |
phv00200111 |
Gender of participant [FEMALE, MALE] |
| GWAS on Cataract and HDL in the PMRP |
phv00071870 |
Gender of participant |
| GWAS on Cataract and HDL in the PMRP |
phv00077312 |
Gender of participant |
| Health and Retirement Study (HRS) |
phv00167516 |
Gender of respondent |
| HeLa S3 (CCL-2.2) HiC Sequencing |
phv00196373 |
Gender of participant [F] |
| High Density SNP Association Analysis of Lung Cancer |
phv00201874 |
Gender of participant [Male, Female] |
| HIV-Resistant People with Hemophilia |
phv00165018 |
Gender of participant |
| Human Autism Genetics and Activity Dependent Gene Activation |
phv00226789 |
Gender of subject |
| Human Gut Microbiome in Amish Obesity |
phv00090513 |
Gender of participant |
| Hypertriglyceridemia Study in Mexicans |
phv00190652 |
Gender of participant |
| ICPCG Genome Wide Association Study of Familial Prostate Cancer |
phv00201571 |
Gender of participant |
| Identification of Genes Involved in Familial Coronary Artery Disease |
phv00171554 |
Gender of participant |
| Identification of Recurrent SMO and BRAF Mutations in Ameloblastomas |
phv00201612 |
Sex of subject |
| IgA Nephropathy GWAS (IGANGWAS) |
phv00218099 |
Gender of participant |
| IgA Nephropathy GWAS (IGANGWAS) |
phv00164712 |
Gender of participant |
| Immunosenescence: Immunity in the Young and Aged |
phv00217650 |
Gender of participant |
| Indianapolis-Ibadan, Nigeria Comparative Epidemiological Study of Dementia |
phv00161465 |
Gender of subject |
| Integration of Genomics and Transcriptomics in unselected Twins and in Major Depression |
phv00171371 |
Gender of participant |
| IPM BioBank GWAS |
phv00162679 |
Gender of subject |
| Ischemic Stroke Genetics Study (ISGS) |
phv00024265 |
Gender of the subject |
| Ischemic Stroke Genetics Study (ISGS) |
phv00034499 |
Gender of participant (male or female) |
| Italian PBC Study |
phv00168044 |
Gender of participant |
| Jackson Heart Study (JHS) Cohort |
phv00125546 |
GENDER OF PARTICIPANT (M,F) Q18 |
| Jackson Heart Study (JHS) Cohort |
phv00125635 |
GENDER OF PARTICIPANT (M,F) Q18 |
| Jackson Heart Study (JHS) Cohort |
phv00125724 |
GENDER OF PARTICIPANT (M,F) Q18 |
| Jackson Heart Study (JHS) Cohort |
phv00125811 |
GENDER OF PARTICIPANT (M,F) Q18 |
| Jackson Heart Study (JHS) Cohort |
phv00126012 |
Gender of participant |
| Jackson Heart Study (JHS) Cohort |
phv00127524 |
4: Participant's gender |
| Jackson Heart Study (JHS) Cohort |
phv00172142 |
Gender of participant |
| Joint Genome-Wide Gene Expression and GWAS Mapping in the MGS Dataset |
phv00202325 |
Gender of participant |
| L1-seq and genome-wide SNP genotyping in a multiethnic Asian population |
phv00201446 |
Gender of participant |
| Longitudinal Genome-Wide Analysis of Patients with Chronic Lymphocytic Leukemia |
phv00218111 |
Gender of participant |
| Megabase-scale Haplotyped Genomic Analysis of Normal and Cancer Genomes |
phv00225801 |
Gender of participant |
| Melanoma Exome Sequencing |
phv00226764 |
Gender of participant |
| Melanoma Genome Sequencing Project |
phv00167383 |
Gender of patient [Male, Female] |
| Metabolism and Genetics of Hypobetalipoproteinemia |
phv00174227 |
Gender of participant |
| Metagenomic Study of the Human Skin Microbiome Associated with Acne |
phv00090394 |
Gender of participant |
| Minnesota Center for Twin and Family Research (MCTFR) |
phv00201962 |
Gender of participant |
| miRNA profiles in serum and CSF of Parkinson's and Alzheimer's patients |
phv00201810 |
Gender of participant |
| MitoExome Sequencing of Mitochondrial OXPHOS Diseases (MGH) |
phv00156596 |
Gender of participant |
| Molecular Defects in Pseudohypoparathyroidism or Related Disorders |
phv00167913 |
Gender of participant |
| Molecular Genetic Analysis of Inherited Kidney Dysfunction |
phv00167971 |
Gender of participant |
| Molecular Profiling of Cancer |
phv00165136 |
Gender of participant |
| Multiethnic Cohort (MEC) Breast Cancer Genetics |
phv00173161 |
Gender of participant |
| N.C. Clinical Genomic Evaluation by NextGen Exome Sequencing (NCGENES) |
phv00222601 |
Gender of participant |
| NCI Genome-Wide Association Study of Renal Cell Carcinoma |
phv00159249 |
Gender of participant |
| NCI GWAS of Lung Cancer in Never Smokers |
phv00201633 |
Gender of participant |
| NCI GWAS of Renal Cell Carcinoma in African Americans |
phv00226593 |
Gender of participant [MALE, FEMALE] |
| NCI Non-Hodgkin Lymphoma GWAS |
phv00225228 |
Gender of participant [MALE, FEMALE] |
| NCI Non-Hodgkin Lymphoma GWAS |
phv00225218 |
Gender of participant |
| NEI Ocular Hypertension Treatment Study (OHTS) |
phv00160401 |
Gender of participant |
| Neurodevelopmental Genomics: Trajectories of Complex Phenotypes |
phv00194003 |
Gender of participant as identified by survey of patient/patient's parent |
| Neurodevelopmental Genomics: Trajectories of Complex Phenotypes |
phv00194909 |
Subject's gender |
| Next Generation Mendelian Genetics: Familial Hemophagocytic Lymphohistiocytosis |
phv00174188 |
Gender of participant |
| NGS in Advanced Cancers |
phv00195642 |
Gender of participant |
| NHGRI Tumor Sequencing Project (Lung Adenocarcinoma) |
phv00071771 |
Gender of participant |
| NHLBI GO-ESP: Family Studies (Aortic Disease) |
phv00179491 |
Gender of participant |
| NHLBI GO-ESP: Family Studies (Atypical Cystic Fibrosis) |
phv00179565 |
Gender of participant |
| NHLBI GO-ESP: Family Studies (Dilated Cardiomyopathy) |
phv00181166 |
Gender of participant |
| NHLBI GO-ESP: Family Studies (Familial Interstitial Pneumonia) |
phv00182046 |
Gender of participant |
| NHLBI GO-ESP: Family Studies (Hematological Cancers) |
phv00196142 |
Gender of participant |
| NHLBI GO-ESP: Family Studies (Mendelian Lipid Disorders) |
phv00195790 |
Gender of participant |
| NHLBI GO-ESP: Family Studies: (Familial Atrial Fibrillation) |
phv00181914 |
Gender of participant |
| NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (SWISS) |
phv00174111 |
GENDER OF PARTICIPANT |
| NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Asthma) |
phv00181856 |
Gender of participant |
| NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Cystic Fibrosis) |
phv00159434 |
Gender of participant |
| NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Cystic Fibrosis) |
phv00159440 |
Gender of participant |
| NHLBI GO-ESP: Women's Health Initiative Exome Sequencing Project (WHI) - WHISP |
phv00161367 |
GENDER OF PARTICIPANT |
| NIDCR Sjogren's International Collaborative Clinical Alliance (SICCA) |
phv00226846 |
Gender of participant |
| NIDDK Gene discovery in FSGS |
phv00202568 |
Gender of participant |
| NIDDK Gene discovery in VUR |
phv00202545 |
Gender of participant |
| NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project |
phv00200477 |
Gender of participant |
| NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project |
phv00088181 |
Gender of participant |
| NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project |
phv00158872 |
Gender of participant |
| NINDS Parkinson's Disease |
phv00023939 |
Gender of subject |
| NINDS Parkinson's Disease |
phv00024005 |
Gender of subject |
| NINDS Parkinsonism Study |
phv00000187 |
Gender of the subject |
| NINDS Repository Cerebrovascular Disease/Stroke Study |
phv00024079 |
Gender of the subject |
| NINDS Repository Motor Neuron Disease/ALS Study |
phv00020520 |
Gender of the subject |
| NINDS Repository Neurologically Normal Control Collection |
phv00000225 |
Gender of the subject |
| Northwestern NUgene Project: Type 2 Diabetes |
phv00158808 |
Gender of participant |
| OMRF SLEGEN GWAS Data from European-American Women with Lupus |
phv00076097 |
Gender of subject |
| Oncogenomics of Malignant Peripheral Nerve Sheath Tumors |
phv00217577 |
Gender of participant |
| Osteosarcoma Genome-wide Association Study |
phv00200964 |
Gender of participant [FEMALE, MALE] |
| Osteosarcoma Genomics |
phv00220907 |
Gender of patient |
| PAGE: Epidemiologic Architecture for Genes Linked to Environment (EAGLE) - BioVU Cancer Project |
phv00196394 |
Gender of participant |
| Paired AML Epigenetics Study on Clonality |
phv00202812 |
Gender of participant |
| Pancreatic Cancer Case-Control Association Study |
phv00226238 |
Gender |
| Pancreatic Cancer Cohort and Case-Control Consortium (PanScan) |
phv00076258 |
Gender of participant [MALE, FEMALE] |
| PGC: the PUWMa GWAS of ADHD |
phv00159878 |
Gender of participant |
| PGRN-RIKEN: Rate Control Therapy in Patients with Atrial Fibrillation |
phv00173383 |
Gender of participant |
| Pharmacogenomics of Anti-Platelet Intervention (PAPI) Study |
phv00173925 |
Gender of participant |
| Pilocytic Astrocytoma in NF1 |
phv00174531 |
Gender of participant |
| POLYGEN |
phv00160468 |
Gender of participant |
| POLYGEN |
phv00160479 |
Gender of participant |
| Primary ER-positive Breast Cancer Treated with Neoadjuvant Letrozole |
phv00222697 |
Gender of participant |
| Prostate Cancer Genome Sequencing Project |
phv00167303 |
Gender of participant [Male, Female] |
| Rapid Whole Genome Sequencing for Genetic Disease Diagnosis in the NICU |
phv00174357 |
Gender of participant |
| Resistance studies in Lung Cancer |
phv00224917 |
Gender of participant |
| Responses to Varicella Zoster Virus Vaccination |
phv00221179 |
Gender of participant |
| Retrotransposition in Colorectal Cancer |
phv00173541 |
Gender of participant |
| RM Epigenomics Program - Broad_Alz_and_Age-Related |
phv00191101 |
Gender of participant |
| RNA-Seq studies of Gene Expression in Cells and Networks in FI and ACC in Autism |
phv00190495 |
Gender of participant |
| RNAseq analysis of posterior cingulate astrocytes in Alzheimer's disease |
phv00201726 |
Gender of participant |
| San Francisco Bay Area Latina Breast Cancer Study |
phv00226550 |
Gender of participant |
| Sensitivity to the subjective effects of amphetamine |
phv00221225 |
Gender of participant |
| Sequence Analysis of Mutations and Translocations Across Breast Cancer Subtypes |
phv00167357 |
Participant's gender as male or female [Male, Female] |
| Sequencing of Targeted Genomic Regions Associated with Smoking |
phv00217965 |
Participant gender |
| Shanghai Breast Cancer Genetics Study (SBCGS) |
phv00217898 |
Gender of participant [female, male] |
| Single Cell Analysis Program - Transcriptome (SCAP-T) |
phv00219205 |
Gender of the subject |
| Skin Microbiome in Disease States: Atopic Dermatitis and Immunodeficiency |
phv00090676 |
Gender of participant [Male; Female] |
| Small Intestine Neuroendocrine Tumors (Carcinoid Tumors) |
phv00190468 |
Participant's gender as Male or Female |
| SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP) |
phv00070936 |
Gender of participant |
| SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP) |
phv00070997 |
Gender of participant |
| SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP) |
phv00071047 |
Gender of participant |
| SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP) |
phv00071105 |
Gender of participant |
| SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP) |
phv00071155 |
Gender of participant |
| SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP) |
phv00071213 |
Gender of participant |
| Somatic Mutations in Variant and IGHV4-34 Expressing Hairy Cell Leukemia |
phv00195931 |
Gender of participant |
| Spectrum of Mutations in Myeloid Neoplasms |
phv00202080 |
Gender of participant |
| Sporadic Amyotrophic Lateral Sclerosis (ALS): Sequencing Study |
phv00252380 |
Biological gender of subject |
| STAMPEED: Northern Finland Birth Cohort 1966 (NFBC1966) |
phv00129605 |
Gender of participant |
| Strabismus, CCDD and Other Anomalies |
phv00167779 |
Gender of participant |
| Strong Activation of Retroviral LTRs in HCC |
phv00225166 |
Gender of participant |
| Study of Adaptation to Hypoxia in Ethiopian Highlanders |
phv00195533 |
Gender of participant |
| Sweden-Schizophrenia Population-Based Case-Control Exome Sequencing |
phv00167461 |
Gender of participant |
| Targeted Sequencing of GWAS Loci in Cleft Lip and Palate |
phv00201753 |
Gender of participant |
| The Detroit Neighborhood Health Study (DNHS) |
phv00174401 |
Gender of participant. |
| The Gene Partnership (TGP) - eMERGE Data |
phv00171962 |
Gender of Subject - as reported by participant |
| The Genetic Landscape of Mutations in Burkitt Lymphoma |
phv00178124 |
Gender of participant |
| The Genomic Complexity of Primary Human Prostate Cancer |
phv00154533 |
Gender of participant |
| The Human Gut Microbiome and Recurrent Abdominal Pain in Children |
phv00091112 |
Gender of participant |
| The Human Virome and Febrile Illness in Children |
phv00098405 |
Gender of participant |
| The Molecular Basis of Inherited Reproductive Disorders |
phv00167992 |
Gender of participant |
| The Mutational Landscape of Head and Neck Squamous Cell Carcinoma |
phv00163064 |
Participant's gender [Male, Female] |
| The Neonatal Microbiome and NEC |
phv00091251 |
Sex of subject |
| The Neonatal Microbiome and NEC |
phv00091258 |
Sex of subject |
| The Role of the Gut Microbiota in Ulcerative Colitis |
phv00091161 |
Participant gender [Male or Female] |
| The UC San Diego Chronic Lymphocytic Leukemia (CLL) Study |
phv00202243 |
Gender of participant |
| Treatment of Genetic Screening of Hypertriglyceridemia type I, III, and V - HTG Amsterdam |
phv00171438 |
Gender of participant |
| Type 1 Diabetes Genetics Consortium (T1DGC): Copy Number Variant (CNV) Study |
phv00226507 |
Gender of participant |
| Type 2 Diabetes in African Americans, GWAS and Exome Sequencing |
phv00066340 |
Gender of participant has been confirmed with genotyping: 1 = Male, 2 = Female |
| Type 2 Diabetes in African Americans, GWAS and Exome Sequencing |
phv00066354 |
Gender of participant has been confirmed with genotyping: 1 = Male, 2 = Female |
| Tyrosine Kinase Mutations in Endometrial Cancer |
phv00221198 |
Gender of participant |
| University of Miami Study on Genetics of Autism and Related Disorders (AutismDisorders) |
phv00171540 |
Gender of participant |
| University of Michigan Clinical Sequencing Exploratory Research (CSER) |
phv00197132 |
Gender of participant |
| University of Washington CSF biomarker study for Parkinson disease |
phv00225944 |
Gender of participant |
| Vanderbilt Genome-Electronic Records (VGER) Project: QRS Duration |
phv00077277 |
Gender of participant |
| VESPA: Genome Wide Study of Vancomycin |
phv00225885 |
Gender of participant |
| VitGene Generalized Vitiligo Genetics Study |
phv00158991 |
Gender of participant |
| Whole Exome and Targeted Sequencing in Tourette Syndrome Multiplex Families |
phv00163339 |
Gender of participant |
| Whole Exome and Transcriptome Sequencing in Sporadic ALS |
phv00201705 |
Gender of participant |
| Whole Exome Sequence of Hearing Loss Family |
phv00252647 |
Gender of participant |
| Whole Exome Sequencing for Colorectal Cancer |
phv00163736 |
Gender of participant |
| Whole Exome Sequencing of Diffuse Large B-Cell Lymphoma |
phv00165116 |
Participant's gender [Male or Female] |
| Whole Genome Association Twin Study of Myopia and Glaucoma Risk Factors |
phv00066468 |
Gender of participant |
| Whole Genome Comparisons of Breast Cancers and their Xenotransplants |
phv00195712 |
Subject's gender |
| Whole Genome Sequencing of Triple Negative Breast Cancer |
phv00124471 |
Gender of participant |
| Whole Genome Sequencing of Two 22q11DS Trios |
phv00222265 |
Gender of participant |
| Whole-Genome and Exome Sequencing in Clear-Cell Renal Cell Carcinoma |
phv00168012 |
Gender of participant |
| Whole-genome sequencing in multiplex epilepsy families |
phv00196481 |
Self-declared gender of participant |
| Whole-Genome Sequencing of Acute Myeloid Leukemia |
phv00073670 |
Gender of participant |
| XPC and Non-XPC Cutaneous Squamous Cell Carcinoma Mutation Rate Study |
phv00252611 |
Gender of participant |